Yuyang D&U Co. Ltd. Forms Joint Venture with Neural Stem Cell Institute
August 22, 2019
Share
Yuyang D&U Co. Ltd. has entered into an agreement with the US Neural Stem Cell Institute (NSCI) to establish a joint venture company named, Luxa Biotechnology LLC (LuxaBio), to develop a treatment for dry macular degeneration. Under the agreement, Yuyang D&U owns 50% stake in LuxaBio for KRW18.25 billion, and will lead the development of therapeutics derived from RPE cells (Retinal Pigment Epithelium Stem Cell) in the entire process from clinical trials to manufacturing, production and sales. Through this agreement, Yuyang D&U will enter the dry macular degeneration market without treatments and strengthen its biocompetitiveness. The JV enables the partners to develop treatment for dry macular degeneration.
Y2 Solution Co Ltd, formerly Yuyang D&U Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of power supply equipment. The Company operates its business through four segments. The Switching Mode Power Supply (SMPS) segment engages in the manufacture and sale of SMPSs for liquid crystal display (LCD), light emitting diode (LED), smart, organic light emitting diode (OLED), and ultra high definition television (UHD TV). The LED segment provides LED lighting products. The Chemical Wholesale segment operates a distribution business that mainly imports petrochemical intermediate raw materials and solvent cleaners from China and Japan, supplies them to demanding enterprises. The Other Business segment is engaged in the development of new biopharmaceuticals, and others.
Y2 SOLUTION CO., LTD 